The analyses identify 3,447 tumor‐specific oncogenic enhancers (SOEs) enriched for master transcription factors (SOX2, TP63, KLF5, GRHL2) that orchestrate malignant programs. The gene discussed is GRHL2; the disease is neoplasm.